ArticleTranslational vision science & technology2026
Detection of Disease Progression Using Widefield Optical Coherence Tomography in the Nonhuman Primate Experimental Glaucoma Model.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: To determine whether there is detectable thinning of the ganglion cell inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) across all eccentricities of a 55° × 45° widefield optical coherence tomography (OCT) scan in the nonhuman primate experimental glaucoma model. Methods: Eight rhesus monkeys (Macaca mulatta) with unilateral experimental glaucoma were monitored longitudinally using widefield OCT. GCIPL and RNFL thickness maps were generated, and longitudinal disease changes were quantified using Z-score maps with 1° × 1° super pixel granularity. For validation, the correspondence between GCIPL volume (mm3) and histologically determined retinal ganglion cell (RGC) counts was determined for 1 mm retinal samples in four longitudinally monitored animals and three additional animals from a separate study. Results: The Z-score maps from follow-up scan sessions demonstrated significant RNFL thinning across the retina, whereas GCIPL thinning was limited to the central 12° in eyes with experimental glaucoma. For the five eccentricities sampled for histology, GCIPL volume was a predictor of RGC counts (F = 44.14, P < 0.01). The linear mixed-effects model, which included eccentricity and disease state, accounted for a substantial portion of the variance (R2 = 0.72). For locations 12.7° and greater, the GCIPL is at a floor in healthy eyes as illustrated by the clustering of disease and control data. Conclusions: Widefield imaging has the potential to quantitatively monitor RNFL wedge defects across a 55° scanned region. GCIPL thickness is a valuable measure of local RGC content in the macular region, but its value for monitoring disease in the periphery is less significant. Translational Relevance: Widefield OCT enables the quantification of retinal ganglion cell associated loss for the extent of the retina tested by visual fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.